drugset / Trial / NCT02018731

L-citrulline and Metformin in Becker's Muscular Dystrophy

NCT02018731

Phase 2 Completed 20 enrolled University Hospital, Basel, Switzerland
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to compare the effects of L-citrulline and metformin and their combination therapy on muscle function and force in patients with Becker muscular dystrophy (BMD).

Timeline

Start
2013-06
Primary completion
2014-09
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject L-citrulline Other / unclassified 5 g Oral
Subject Metformin Small molecule 500 mg Oral